Login

In-Depth C-Suite Interview with ACCO Brands CEO Boris Elisman | Boris Elisman, CEO , ACCO Brand. 00:10:00

Share On Facebook Share On Twitter

Explore the strategic insights of Boris Elisman, CEO of ACCO Brands (ACCO), in an exclusive C-Suite interview featured on Channelchek. Gain access to PREMIUM content where small and microcap executives, along with award-winning analysts from Noble Capital Markets, discuss the future of ACCO Brands and the industry landscape.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
Mamba Exploration's Mike Dunbar on High-Grade Hyden REE Project Acquisition and Potential | Mike Dunbar , CEO ,Mamba Exploration.
00:00:00
Explains why getting the COVID-19 vaccine is more important than ever - John (Jack) C. O'Horo, M.D. , Mayo Clinic
00:10:00
extraordinary people capable of changing the thing|Madison McIlwain,Partner,Defy.vc
00:10:00
EQT's 2021 Achievements and Future Goals: Christian Sinding's Address | Christian Sinding, CEO, EQT.
00:10:00
provides investable assets for diverse angel investors to fund tomorrow's companies|Mark Kraynak,Founding Partner,Acrew Capital
00:10:00
Phost's Breakthrough in Neurodegenerative Disease Treatment: CEO Michael Thern on Accelerated FDA Approval for Monipentel|Dr Michael Thurn,Managing Director & Chief Executive Officer,PharmAust Ltd.
00:10:00
Building Strong Partnerships: A CEO's Perspective on Emira Property Fund's Relationship with RMB Bank | Geoffrey Michael Jennett, CEO, Emira Property Fund.
00:10:00
Estrada: Revolutionizing Nickel and Cobalt Mining with Innovative Approach
00:10:00
Arrow Minerals: Exploring Gold Potential in Australia and Burkina Faso
00:10:00
This is such an insightful and transparent discussion about the challenges and transformations your company went through.
00:10:00
Interview with Mike on the Transformative Potential of Hydrogen Projects: Insights Ahead of the World Hydrogen Congress North America 2023
00:00:00
Dr. Shamu is a broadly trained cell biologist / Caroline Shamu, PhD Associate Dean for Research Cores and Technology, HMS

© 2017 - Townhall + Tv